glp-1 for psoriasis Drugs: Easing While Shedding Pounds Emerging research suggests that GLP-1–based
Description
For weight management in patients without diabetes, the situation is more nuanced but current evidence suggests that obesity should also be treated as a chronic condition requiring ongoing management
Similar content being viewed by others Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are standard-of-care agents that provide potent glucose-lowering without hypoglycemia, together with weight reduction and cardiovascular and renal benefits
As they become more widely used, they could potentially face similar legal scrutiny if severe adverse events emerge
doi: 10.1177/1557988319835985
Yes, both platforms generally allow patients to upload recent labs when clinically appropriate, which can reduce repeat testing costs
